(Q34568682)

3 August 2017

Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle (English)

1 reference

3 August 2017

Choongho Lee

1

1 reference

3 August 2017

Tonia R Wooldridge

series ordinal

2

1 reference

3 August 2017

Laimonis A Laimins

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

26 September 2006

1 reference

3 August 2017

1 reference

3 August 2017

358

1 reference

3 August 2017

1

1 reference

3 August 2017

201-210

1 reference

Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Identification of an alpha helical motif sufficient for association with papillomavirus E6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Telomerase activation by the E6 gene product of human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Genital human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus life cycle: active and latent phases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Papillomaviruses and cancer: from basic studies to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

7 January 2021

Human papillomaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

7 January 2021

The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

7 January 2021

DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

7 January 2021

Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.028

7 January 2021

10.1016/J.VIROL.2006.08.028

Identifiers

DOI

1 reference

3 August 2017

1 reference